Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01245
|
|||||
| Drug Name |
Dicarboxylate
|
|||||
| Synonyms |
1,3-Propanedioic acid; 9KX7ZMG0MK; AI3-15375; BRN 1751370; CHEBI:30794; Carboxyacetic acid; DICARBOXYLIC ACID C3; Dicarboxylate; Dicarboxylic acid; Dicarboxymethane; EINECS 205-503-0; Kyselina malonova; Kyselina malonova [Czech]; METAHNEDICARBOXYLIC ACID; MFCD00002707; Malonic acid; Malonic acid, 99%; Methanedicarbonic acid; Methanedicarboxylic acid; NSC 8124; NSC8124; OFOBLEOULBTSOW-UHFFFAOYSA-N; PROPANEDIOLIC ACID; Thallium malonate; UNII-9KX7ZMG0MK; USAF EK-695; alpha,omega-Dicarboxylic acid; malonic acid; propanedioic acid
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C3H4O4
|
|||||
| Canonical SMILES |
C(C(=O)O)C(=O)O
|
|||||
| InChI |
InChI=1S/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7)
|
|||||
| InChIKey |
OFOBLEOULBTSOW-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 141-82-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 104.06 | Topological Polar Surface Area | 74.6 | ||
| Heavy Atom Count | 7 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
-0.8
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:30794
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | NADC1 | Transporter Info | Sodium/dicarboxylate cotransporter 1 | Substrate | [1] | |
| NADC3 | Transporter Info | Sodium/dicarboxylate cotransporter 3 | Substrate | [2] | ||
| References | ||||||
| 1 | Evidence for epistatic interaction between VDR and SLC13A2 genes in the pathogenesis of hypocitraturia in recurrent calcium oxalate stone formers. J Nephrol. 2017 Jun;30(3):411-418. | |||||
| 2 | SLC13A3 variants cause acute reversible leukoencephalopathy and -ketoglutarate accumulation. Ann Neurol. 2019 Mar;85(3):385-395. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.